List view / Grid view
Filter the results
A study has suggested that while funding for artificial intelligence in pharma was $5.2bn in 2019, overall investment is slowing.
Article: Fast HPLC using fused-core particle technology for rapid screening of pharmaceutical compounds
HPLC is critical to the discovery, development and eventual commercialization of pharmaceutical products. HPLC is the benchmark analytical method in the pharmaceutical industry due to its ability to score such high marks in analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.
Generic screening to provide fast solutions for chiral method development, whether needed for routine analytical use, trace analysis, LC/MS or preparative LC, has become increasingly important.
Application note: Benchmarking the Microsart® AMP Mycoplasma kit against products from two other suppliers
This application note compares Sartorius' Microsart AMP Mycoplasma kit with two other mycoplasma detection kits that are also based on DNA isolation with subsequent real-time PCR analysis.
Herewith ACD/Labs presents their web-based software solution to the multiple challenges experienced in screening workflows; offering effective support for high-throughput catalyst screening.
The Multitron is the number-one choice for reliable, convenient cultivation of microorganisms and cell cultures. The incubation shaker guarantees homogeneous conditions and delivers reproducible results, leaving nothing to be desired regarding its features and capacity.
Mayo study uses artificial intelligence to create inexpensive, widely available early detector of heart disease...
A blood test has been developed to detect pancreatic cancer at its earliest stages with an accuracy rate of 96 percent...
Scientific Poster: From Screening to Small Scale GMP Biomanufacturing: Exploring a simple, unified platform strategy for handling a range of cell culture needs
This poster discusses a process for a 12-week clone development process. The process starts in silico, and progresses through screening and clone selection in 96-deepwell plates up to five liter shaker flasks...
Researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the FDA to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.
The FDA has approved tests intended to be used as donor screening tests on samples from individual human donors, including volunteer donors of whole blood and blood components...